Healthcare | April 06, 2026
AstraZeneca, Roche-backed study supports risk-based HF screening in diabetes
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
Safety was equally impressive. ENV-294 was well tolerated
Board approves five-year appointment, subject to shareholder nod through postal ballot
Developed for today’s fast-paced, visually demanding lifestyles, the lenses are built on ZEISS NeurOptix technology
The SirPAD trial marks a significant milestone in vascular intervention, positioning MagicTouch PTA as a promising future alternative for PAD treatment
The innovation leverages Mitsui Chemicals’ oxygen-permeable InnoCell cell culture plate to efficiently collect bile while reducing stress on liver cells
The trial demonstrated that immune responses in children were non-inferior to adults, with a similar safety profile after two standard doses of MVA-BN
The decision is based on the phase 3 DESTINY-Breast11 trial
The findings were presented as a late-breaking study at the 2026 American Academy of Dermatology
High-level results from the Phase III OBERON and TITANIA trials revealed that the first-in-class monoclonal antibody reduced the annual rate of moderate-to-severe COPD exacerbations compared with placebo
Subscribe To Our Newsletter & Stay Updated
